Equibles does not estimate personal net worth.
Get an email with a short summary when ClearPoint Neuro, Inc. publishes a filing, an earnings call transcript or a press release.
Get CLPT alertsJoe Burnett is recorded as CEO at ClearPoint Neuro, Inc. (CLPT). Joe Burnett has spoken on 19 earnings calls across 1 company, most recently for ClearPoint Neuro, Inc. on October 28, 2026. ClearPoint Neuro, Inc. is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at ClearPoint Neuro, Inc. includes R. John Fletcher (Chairman and Board Member), Danilo D’Alessandro (CFO), Mazin Sabra (COO) and 7 others.
“And good evening to all the investors, analysts, and partners joining us for today's ClearPoint Neuro third quarter earnings call. Our company remains dedicated to developing therapies that can help restore function and improve outcomes for millions of patients worldwide living with serious neurological disorders.”
“Thank you, and as always, thank you to all the investors, analysts, and biopharma partners listening to today's call. We remain both committed to and focused on developing a complete neuro ecosystem capable of delivering various minimally invasive of treatments, including cell and gene therapies to the brain.”
“And as always, thank you to all of the investors, analysts, and biopharma partners listening to today's call. We remain both committed to and focused on developing a complete neuroecosystem capable of delivering various minimally invasive treatments, including cell and gene therapies to the brain.”
“And as always, thank you to all of the investors, analysts, and biopharma partners listening to today's call. We remain both committed to and focused on developing a complete neuroecosystem capable of delivering various minimally invasive treatments, including cell and gene therapies to the brain.”
“Thank you, Sherry, and thank you to all of the investors and analysts today joining us on today's call. This is an important and truly exciting moment in the history of ClearPoint as we enter the next phase of the company.”
Medical Devices · Healthcare
CEO
